Chromosomal aberrations in canine gliomas define candidate genes and common pathways in dogs and humans

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Spontaneous gliomas in dogs occur at a frequency similar to that in humans and may provide a translational model for therapeutic development and comparative biological investigations. Copy number alterations in 38 canine gliomas, including diffuse astrocytomas, glioblastomas, oligodendrogliomas, and mixed oligoastrocytomas, were defined using an Illumina 170K single nucleotide polymorphism array. Highly recurrent alterations were seen in up to 85% of some tumor types, most notably involving chromosomes 13, 22, and 38, and gliomas clustered into 2 major groups consisting of highgrade IV astrocytomas, or oligodendrogliomas and other tumors. Tumor types were characterized by specific broad and focal chromosomal events including focal loss of the INK4A/B locus in glioblastoma and loss of the RB1 gene and amplification of the PDGFRA gene in oligodendrogliomas. Genes associated with the 3 critical pathways in human high-grade gliomas (TP53, RB1, and RTK/RAS/PI3K) were frequently associated with canine aberrations. Analysis of oligodendrogliomas revealed regions of chromosomal losses syntenic to human 1p involving tumor suppressor genes, such as CDKN2C, as well as genes associated with apoptosis, autophagy, and response to chemotherapy and radiation. Analysis of high frequency chromosomal aberrations with respect to human orthologues may provide insight into both novel and common pathways in gliomagenesis and response to therapy.

Original languageEnglish (US)
Pages (from-to)700-710
Number of pages11
JournalJournal of Neuropathology and Experimental Neurology
Volume75
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Oligodendroglioma
Glioma
Chromosome Aberrations
Canidae
Astrocytoma
Dogs
Glioblastoma
Genes
Chromosomes, Human, Pair 22
Chromosomes, Human, Pair 13
Neoplasms
Critical Pathways
Gene Amplification
Autophagy
Tumor Suppressor Genes
Phosphatidylinositol 3-Kinases
Single Nucleotide Polymorphism
Radiation
Apoptosis
Drug Therapy

Keywords

  • Astrocytoma
  • Brain tumor
  • Cancer genomics
  • Copy number alteration
  • Dog
  • Glioma
  • Oligodendroglioma
  • Single nucleotide polymorphism (SNP)

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

@article{c2741d72b96545128e7568ad58b949ce,
title = "Chromosomal aberrations in canine gliomas define candidate genes and common pathways in dogs and humans",
abstract = "Spontaneous gliomas in dogs occur at a frequency similar to that in humans and may provide a translational model for therapeutic development and comparative biological investigations. Copy number alterations in 38 canine gliomas, including diffuse astrocytomas, glioblastomas, oligodendrogliomas, and mixed oligoastrocytomas, were defined using an Illumina 170K single nucleotide polymorphism array. Highly recurrent alterations were seen in up to 85{\%} of some tumor types, most notably involving chromosomes 13, 22, and 38, and gliomas clustered into 2 major groups consisting of highgrade IV astrocytomas, or oligodendrogliomas and other tumors. Tumor types were characterized by specific broad and focal chromosomal events including focal loss of the INK4A/B locus in glioblastoma and loss of the RB1 gene and amplification of the PDGFRA gene in oligodendrogliomas. Genes associated with the 3 critical pathways in human high-grade gliomas (TP53, RB1, and RTK/RAS/PI3K) were frequently associated with canine aberrations. Analysis of oligodendrogliomas revealed regions of chromosomal losses syntenic to human 1p involving tumor suppressor genes, such as CDKN2C, as well as genes associated with apoptosis, autophagy, and response to chemotherapy and radiation. Analysis of high frequency chromosomal aberrations with respect to human orthologues may provide insight into both novel and common pathways in gliomagenesis and response to therapy.",
keywords = "Astrocytoma, Brain tumor, Cancer genomics, Copy number alteration, Dog, Glioma, Oligodendroglioma, Single nucleotide polymorphism (SNP)",
author = "Dickinson, {Peter J} and Daniel York and Robert Higgins and Lecouteur, {Richard A} and Nikhil Joshi and Bannasch, {Danika L}",
year = "2016",
month = "7",
day = "1",
doi = "10.1093/jnen/nlw042",
language = "English (US)",
volume = "75",
pages = "700--710",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Chromosomal aberrations in canine gliomas define candidate genes and common pathways in dogs and humans

AU - Dickinson, Peter J

AU - York, Daniel

AU - Higgins, Robert

AU - Lecouteur, Richard A

AU - Joshi, Nikhil

AU - Bannasch, Danika L

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Spontaneous gliomas in dogs occur at a frequency similar to that in humans and may provide a translational model for therapeutic development and comparative biological investigations. Copy number alterations in 38 canine gliomas, including diffuse astrocytomas, glioblastomas, oligodendrogliomas, and mixed oligoastrocytomas, were defined using an Illumina 170K single nucleotide polymorphism array. Highly recurrent alterations were seen in up to 85% of some tumor types, most notably involving chromosomes 13, 22, and 38, and gliomas clustered into 2 major groups consisting of highgrade IV astrocytomas, or oligodendrogliomas and other tumors. Tumor types were characterized by specific broad and focal chromosomal events including focal loss of the INK4A/B locus in glioblastoma and loss of the RB1 gene and amplification of the PDGFRA gene in oligodendrogliomas. Genes associated with the 3 critical pathways in human high-grade gliomas (TP53, RB1, and RTK/RAS/PI3K) were frequently associated with canine aberrations. Analysis of oligodendrogliomas revealed regions of chromosomal losses syntenic to human 1p involving tumor suppressor genes, such as CDKN2C, as well as genes associated with apoptosis, autophagy, and response to chemotherapy and radiation. Analysis of high frequency chromosomal aberrations with respect to human orthologues may provide insight into both novel and common pathways in gliomagenesis and response to therapy.

AB - Spontaneous gliomas in dogs occur at a frequency similar to that in humans and may provide a translational model for therapeutic development and comparative biological investigations. Copy number alterations in 38 canine gliomas, including diffuse astrocytomas, glioblastomas, oligodendrogliomas, and mixed oligoastrocytomas, were defined using an Illumina 170K single nucleotide polymorphism array. Highly recurrent alterations were seen in up to 85% of some tumor types, most notably involving chromosomes 13, 22, and 38, and gliomas clustered into 2 major groups consisting of highgrade IV astrocytomas, or oligodendrogliomas and other tumors. Tumor types were characterized by specific broad and focal chromosomal events including focal loss of the INK4A/B locus in glioblastoma and loss of the RB1 gene and amplification of the PDGFRA gene in oligodendrogliomas. Genes associated with the 3 critical pathways in human high-grade gliomas (TP53, RB1, and RTK/RAS/PI3K) were frequently associated with canine aberrations. Analysis of oligodendrogliomas revealed regions of chromosomal losses syntenic to human 1p involving tumor suppressor genes, such as CDKN2C, as well as genes associated with apoptosis, autophagy, and response to chemotherapy and radiation. Analysis of high frequency chromosomal aberrations with respect to human orthologues may provide insight into both novel and common pathways in gliomagenesis and response to therapy.

KW - Astrocytoma

KW - Brain tumor

KW - Cancer genomics

KW - Copy number alteration

KW - Dog

KW - Glioma

KW - Oligodendroglioma

KW - Single nucleotide polymorphism (SNP)

UR - http://www.scopus.com/inward/record.url?scp=84983247608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983247608&partnerID=8YFLogxK

U2 - 10.1093/jnen/nlw042

DO - 10.1093/jnen/nlw042

M3 - Article

C2 - 27251041

AN - SCOPUS:84983247608

VL - 75

SP - 700

EP - 710

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 7

ER -